PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
From:
Antivir Ther. Author manuscript; available in PMC Jan 1, 2011.
Published in final edited form as:
Antivir Ther. 2010; 15(4): 571–577.
doi: 10.3851/IMP1557
Table 1
Characteristics of Study Participants at Index Visita
VariableHIV-InfectedHIV-UninfectedP-valueb
No. of women315109

Age (yr)43.7 ± 8.041.5 ± 8.90.063

Race/ethnicity

 African American46 (14.6%)10 (9.2%)

 Hispanic184 (58.4%)66 (60.6%)

 White77 (24.4%)33 (29.3%)

 Other8 (2.5%)1 (0.9%)0.30

HIV risk group

 Injection drug use112 (34.8%)28 (25.7%)

 Heterosexual123 (38.9%)31 (28.4%)

 Blood transfusion9 (2.6%)5 (4.6%)

 None69 (23.6%)45 (41.3%)< 0.001

Clinical AIDS at or before visit164 (52.1%)NA

Body mass index (kg/m2)30.6 ± 8.135.1 ± 8.7< 0.001

CD4 count (/mm3), median (interquartile range)502 (260, 661)NA

HIV viral load (log10 copies/mm3)2.86 ± 1.09NA

Detectable HIV viral load143 (42.1%)NA

HCV RNA positive132 (42.0%)67 (63.2%)0.26

Fasting glucose (mg/dL)136 ± 71142 ± 660.17

Hemoglobin A1C (%)6.4 ± 2.06.8 ± 2.00.025

Mean corpuscular volume (fl)97.0 ± 12.288.0 ± 8.0< 0.001
aContinuous variables are expressed as mean ± standard deviation (unless otherwise specified) and categorical values are expressed as n (%)
bChi-square test for categorical variables and Wilcoxon rank-sum test for continuous variables